1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026

  • July 2017
  • 395 pages
  • ID: 5103462
In this report:
THE GLOBAL AML MARKET, DEFINED AS THE SALES OF BRANDED THERAPEUTICS AND GENERIC CHEMOTHERAPY REGIMENS IN THE US, FRANCE, GERMANY, ITALY, SPAIN, THE UK, AND JAPAN, IS EXPECTED TO GROW FROM $##M IN 2016 TO $##.##B IN 2026, AT A COMPOUND ANNUAL GROWTH RATE (CAGR) OF ##.##%.
THE US IS THE LARGEST GLOBAL AML MARKET, AND SALES ARE EXPECTED TO INCREASE FROM $##M IN 2016 TO $##.##B IN 2026, AT A CAGR OF ##.##%.

Summary

Table of Contents

Search Inside

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026

Brief

Acute myeloid leukemia is a quickly progressing blood cancer with a poor global prognosis. AML is relatively rare, and predominantly affects older adults. Although a number of acquired genetic and molecular abnormalities have been implicated in the manifestation of AML and disease progression, in most cases the stimuli causing these abnormalities to occur have not been identified.

Major drivers of the AML market in the 7MM will include a rising number of elderly incident cases of AML, particularly in the US, the launch of premium-priced therapies, including AbbVie/Roche's Venclexta, Celgene's enasidenib and CC-486, and Actinium's Iomab-B for elderly AML patients; Daiichi Sankyo's quizartinib and Astellas' gilteritinib for FLT3-mutated AML; and Jazz's Vyxeos for newly diagnosed elderly secondary AML patients, and a growing branded drug treatment rate, particularly among elderly patients.

Barriers to the growth of the AML market in the 7MM will include a high enrollment rate of AML patients in clinical trials in the 5EU, the U.S., and Japan (JP), pressure for cost-consciousness, particularly in the EU, limited adoption of the branded therapies due to positioning of most of them in combination with the relatively toxic current standard-of-care regimens, loss of patent protection of Vidaza, Dacogen, Rydapt, and the prospective branded therapies Vyxeos and guadecitabine.

Key questions & answers

- The AML market is marked by the presence of a number of unmet needs in current treatments. What are the principal unmet needs in this sector? Will the drugs under development fulfil the unmet needs of the AML market?

- How will additional pipeline agents including Rydapt, enasidenib, Mylotarg, Vyxeos, and Venclexta impact the AML market?

- The current AML market is dominated by generic chemotherapies. How will the advent of targeted prescription drugs change the drug treatment landscape in AML? How will the drug treatment rate change over the next five years? What are the main drivers and barriers to this change?

Overview

- Overview of AML, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.

- Annualized AML therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in nine patient segments , estimate from 2016 to 2026.

- Key topics covered include tactical competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the AML therapeutics market.

- Pipeline analysis: exhaustive data assessing emerging trends and mechanisms of action under development for AML. The most favorable candidate in Phase III development are profiled.

- Analysis of the current and future market competition in the overall AML market. Insightful review of the top industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Great reasons to purchase

The market research will enable you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most strong pipeline.

- Develop strategic management by understanding the trends shaping and driving the overall AML market.

- Drive revenues by understanding the main trends, innovative products and technologies, market segments, and firms likely to impact the overall AML market in the outlook.

- Specified effective sales and marketing strategies by understanding the challenging landscape and by analysing the performance of different competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a ambitious advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and tactical partnerships.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
TNF Inhibitors - A Pipeline Analysis Report

TNF Inhibitors - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

TNF Inhibitors: An insightThe TNF inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global TNF inhibitors market. The anti-TNF drugs are among the top 10 global ...

Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

Stem cell therapy for diabetes and related conditions: An insightThe stem cell therapy for diabetes and related conditions pipeline analysis report includes ongoing clinical and non-clinical trends in ...

Plasma Protease C1-inhibitor Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Plasma Protease C1-inhibitor Treatment Industry: Forecasts to 2025

  • $ 5795
  • Industry report
  • October 2017
  • by Transparency Market Research

Global Plasma Protease C1-inhibitor Treatment Market: OverviewThis report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large numbe ...


Download Unlimited Documents from Trusted Public Sources

Vaccine Market and Influenza Statistics in India

  • December 2017
    6 pages
  • Vaccine  

    Influenza  

    Diabetes  

  • India  

    United States  

View report >

Therapy Market

  • December 2017
    12 pages
  • Therapy  

    Therapy  

View report >

Hormone and Therapy Market in Pakistan and the US

  • December 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.